Skip to content

Programs
Client Portfolio
Services
- Access to Funding
- Venture Advisory Services
About
Contact
Media

Menu

Programs
Client Portfolio
Services
- Access to Funding
- Venture Advisory Services
About
Contact
Media

liver disease

Loading...

Default Featured Image

News

Oklahoma-based Kirrhos Pharmaceuticals tackles fatty liver disease known as NASH

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

Client Portfolio
About Us
Media
Events
Contact
Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

E3
ACT Tulsa
Love's Entrepreneur's Cup
OKBio

Client Portfolio

Services

Access to Funding
Venture Advisory Services

Contact

About

Our Values
Our Team
Board of Directors
Corporate Partners

Media